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Thymocytes differentiate into two mutually exclusive subsets of T  lymphocytes 
that can  be distinguished  by the expression of the T4 and T8 surface proteins 
(1). T4 + and T8 + subsets can be further distinguished with respect to recognition 
of distinct classes of major histocompatibility complex (MHC)' molecules, as well 
as expression of different  immunological  function.  T4 + lymphocytes recognize 
foreign  antigen  predominantly  in  conjunction  with  class  II  MHC  molecules, 
while T8 + cells recognize antigen predominantly in association with class I MHC 
molecules (2-4).  Functionally, the T4 + subset contains the majority of helper T 
cells, while the T8 + subset is devoid of helper cells but contains the majority of 
cytotoxic and suppressor T  cells (5). The relationship of the T4 ÷ subset to MHC 
recognition of class II molecules is probably more stringent than the relationship 
of T4  expression  to  helper  function,  since  T4 + lymphocytes are  functionally 
heterogeneous, and can be induced to differentiate into cytotoxic and suppressor 
cells (6-8). 
Recently,  data  from  many  laboratories  (9-16)  have  suggested  that  the  T4 
molecule is not solely a marker of a unique T  cell subset, but plays a crucial role 
in  both  the  inductive  and  effector  phases  of T  cell  functions.  For  example, 
monoclonal antibodies (mAb) directed against certain epitopes of the T4 glyco- 
protein inhibit antigen-induced in vitro proliferation (9), lymphokine release (10, 
11), helper cell function (12), as well as autologous reactions induced by class II- 
bearing stimulator cells (13).  In addition, antibodies against T4 inhibit cytotoxic 
activity  of  T4 +  lymphocytes  specific  for  target  cells  bearing  class  II  MHC 
determinants  (! 4-16). Taken  together,  these data have been interpreted  to be 
consistent with the hypothesis that the T4 molecules are receptor structures for 
nonpolymorphic regions of class II molecules (10,  14,  15).  Alternative interpre- 
tations  of the  antibody  inhibition  studies  are  that  the  interaction  of anti-T4 
antibodies  with  the  T4  molecule  delivers  a  negative  signal  to  T4 +  ceils,  or 
interferes with the recognition of important non-MHC structures on stimulating 
and target cells. 
To study these possibilities in  greater detail,  we have triggered  T4 + cells in 
vitro with antibodies against the T3 surface molecule, in the presence or absence 
of antibodies  to  the  T4  molecule.  T3  is the  20/25  kilodalton  (kD)  molecular 
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complex known to be physically associated with the polymorphic T  cell receptor 
for  antigen  (17-19).  Anti-T3  triggering  mimics  antigen  activation  even  with 
respect to the requirement for accessory cells (20). We have found that antibodies 
to certain epitopes of T4 inhibit anti-T3 activation of T4 + cells. This inhibition 
by  anti-T4  was  observed  even  under  experimental  conditions  in  which  the 
accessory cell was devoid of MHC class II molecules. In addition, we have found 
that  T4  cells depleted  of accessory cells can  be triggered  by anti-T3  bound  to 
Sepharose beads, and this activation is also inhibited by anti-T4 antibodies. Thus, 
perturbation  of  the  T4  molecule  can  deliver  inhibitory  signals  to  T  cells, 
independent of MHC class II recognition. 
Materials and  Methods 
Lymphocyte Preparation and Isolation of T Cells.  Fresh peripheral blood mononuclear 
cells were isolated from consenting human volunteers by Ficoll hypaque density gradient 
centrifugation.  The methods for isolation of lymphocyte subpopulations and distinct T 
cell subsets have been previously described (21).  On the basis of erythrocyte (E) rosette 
formation with sheep red blood cells (SRBC), cells were further fractionated into E  ÷ (T 
cells) and E- (non-T cells).  E + cells were further treated by 1-h adherence to plastic petri 
dishes at 37°C in a humidifed atmosphere with 5% CO2. Nonadherent E  + cells (T cells) 
were then negatively selected as follows: T4  + cells were negatively selected from the E  ÷ 
population by treatment with OKT8 and OKM 1 antibody plus complement (C). T8  + cells 
were selected by the use of OKT4 and OKM 1 antibody plus complement (22). Phenotypic 
analysis of the resulting populations by cytofluorography showed that the OKT8-treated 
population contained >90% OKT3 + cells, >90% OKT4  + cells,  <2.0% OKT8  + cells, and 
<1% OKM 1  + cells. The OKT4-treated population contained >90% OKT3 + cells, >85% 
OKT8  + cells, <10% OKT4  + cells, and <1% OKM1 + cells. 
Monoclonal Antibodies.  mAb were used  in  the ascites form or as purified antibodies 
prepared from ascites as described  (23).  The  mAh  used  in  these  studies  were  OKT4 
(IgG2), OKT4C (IgG1), OKT1 (IgGl), OKT3 (IgG2), OKI2 (IgG1), and OKT8A (IgG2). 
OKT4 and OKT4C react with noncompeting epitopes of the T4 molecule (24).  OKT1 
binds to >90%  of peripheral T  cells (25).  OKI2 recognizes nonpolymorphic antigenic 
determinants of class  II MHC products (26).  All  ascites antibodies were used at a  final 
dilution  of  1:100-1:200.  OKT3  was  used  in  purified  form at a  final  dilution  of 500 
ng/ml. Coupling of purified OKT3 to CNBr-activated Sepharose 4 B beads was performed 
as described by the manufacturer (Pharmacia Fine Chemicals, Uppsala, Sweden). 
Cultures.  The final medium for all cultures consisted of Iscoves modified Dulbecco's 
medium  (IMDM)  supplemented  with  1%  penicillin-streptomycin  (Gibco  Laboratories, 
Grand Island, NY)and 10% fetal calf serum (HyCIone Laboratories, Logan, UT). T cells 
were placed in  culture at a final concentration of 106 cells/ml in a volume of 200 ~1, in 
96-well, flat-bottom microtiter plates (Costar, Cambridge, MA).  E- accessory cells  were 
irradiated  with  2,000  rad  before  addition  to  culture.  The  cell  line  U937  (27)  was 
maintained  in  bulk culture at a  concentration  of 0.5  x  106  cells/ml.  For proliferative 
experiments,  U937  cells were irradiated  (7,000  tad) and added  to the cultures at the 
indicated  concentrations.  The phenotype of U937  was Ia-, OKMI  ÷, OKM5 +,  OKT3-, 
OKT4 +, and OKT8-. Proliferation was assessed in triplicate after 72 h of cell culture by 
[3H]thymidine (1  uCi/well;  New England  Nuclear,  Boston, MA) incorporation as previ- 
ously described (21). 
In experiments in which anti-T3 bound to Sepharose beads were used, cultures were 
performed in  round-bottom plates.  To achieve maximum proliferation,  -1,000  beads 
were added per culture. 
Results 
Antibodies to Certain Epitopes of the T4 Molecule Inhibit Anti-T3 Activation of T4 
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OKT3  in  the  presence of varying concentrations of accessory E- cells.  At  the 
initiation  of cell  culture,  antibodies  raised  against  distinct  epitopes  of the  T4 
molecule  (OKT4  and  OKT4C),  as  well  as  a  control  antibody,  OKT1,  were 
added, and T  cell activation was assessed 72  h  later by [3H]tbymidine incorpo- 
ration.  A  representative experiment is shown in  Fig.  1.  The activation of T4  + 
cells  by  OKT3  was  dependent  on  E-  accessory  cells,  and  this  activation  was 
markedly inhibited by OKT4C. In contrast, OKT4 was only minimally inhibitory, 
and the control antibody, OKT1, had no inhibitory effects. Since OKT4C and 
OKT1  are both IgG1  antibodies,  the inhibition by OKT4C was not a  function 
of isotype alone.  The inhibition by OKT4C but not OKT1  is dose dependent, 
with significant inhibition  observed at concentrations of OKT4C as low as 2.5 
~g/ml (Fig. 2). 
To rule out nonspecific inhibitory properties of OKT4C antibodies, as well as 
to assess  the tissue  specificity of the  inhibition,  OKT4C  was  added  to  OK.T3- 
activated T4  + and T8  + subsets in the presence of E- accessory cells. As shown in 
Fig. 3, OKT4C markedly inhibited activation of T4  + cells, but had no significant 
effect on the OKT3-activated T8  + cells. Thus, the inhibition observed was not 
nonspecific,  but  was  dependent on the interaction  of OKT4C  with  T4  + cells. 
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FIGURE  1.  T4 + ceils,  106 cells/ml, were incubated with OKT3  (500 ng/ml) in the presence 
of increasing numbers of irradiated E- cells (0). At the beginning of the culture, mAb OKT4C 
(If),  OKTI  (A) or OKT4  (1-1) were added.  [3H]Thymidine incorporation  was measured after 
72 h. Antibodies were used at concentrations as described. 
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FIGURE  2.  T4  + cells (106 cells/ml) were incubated in the presence of OKT3 (500 ng/ml) and 
irradiated  E- cells (0.2  x  106 cells/ml).  Proliferation  was measured by [SH]thymidine incor- 
poration after 72 h (- -  -). OKT4C (11) or OKT 1 (I--1) were added at increasing concentrations. BANK AND  CHESS  1297 
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F]GURE 3.  T  cells were fractionated  by antibody  plus C treatment into TB+T4  -  (A) and 
T4÷T8  - (B) populations. The respective populations were triggered with OKT3 and irradiated 
autologous E- cells, and proliferation  was measured after 72 h. 
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FIGURE 4.  T4- ceils  (10  a cells/ml) were  cultured in the presence  of OKT3 (500 ng/mI) and 
E- cells  (0.2 x  I0" cells/ml).  The antibodies  OKT4C (II), OKTI (A) or OKT4 (F-l) were  added 
at time  0,  and  cultures  were  harvested  after  1,  2,  3,  and  5 d  of culture;  [3H]thymidine 
incorporation  was measured. The control cultures (no antibody) are labeled (0). 
Conversely,  OKT8  inhibited  the  proliferation  of T8 ÷  cells,  as  previously  de- 
scribed (28). 
One  interpretation  of the  inhibition  by OKT4C  observed above is  that  the 
antibodies altered  the kinetics of OKT3-induced proliferation of T4  ÷ cells.  To 
address this point, we assessed the proliferative response of T4 + cells triggered 
by OKT3  in  the  presence or absence of OKT4C,  and  terminated  the cultures 
on  various  days.  In  the  representative  experiment  shown  in  Fig.  4,  OKT4C, 
when added at the  initiation  of culture,  inhibited  OKT3  activation throughout 
the culture  periods (days  1-5).  Therefore,  OKT4C  was not  inducing a  shift in 
the  kinetics  of T3  activation.  In  a  related  experiment,  OKT4C  was added  to 
OKT3-activated  T4 + cells  at  various  times  after  the  initiation  of cell  culture. 
Inhibition  was  marked only when  OKT4C  was added  during  the  first  24  h  of 
cell culture.  No inhibition  was seen when OKT4C  was added at 48 h  of culture 
(Fig.  5).  These  studies  show  that  OKT4C  is  not  nonspecifically  cytotoxic  or 
interfering with [3H]thymidine incorporation. 
Inhibition of OKT3-activated T4 + Cells by OKT4C Is Not Dependent on Ia ÷ Accessory 
Cells.  In  the  next  series  of experiments,  we  asked  whether  the  inhibition  of 
OKT3-activated T4 ÷ cells by OKT4C  depends on the presence of Ia  + accessory 
cells.  Since OKT3  activation is dependent on  E- cells, which contain  Ia  + mono- 
cytes and  B  cells  (Fig.  1),  we  devised  alternative  experimental  approaches  to 
activating T4 + cells by OKT3  in the absence of Ia  + cells.  First, we asked whether 
the  accessory cell  function  of E- cells could  be replaced  by the  human  myelo- 
monocytic cell line, U937,  which does not express Ia on the cell surface. 
We found that, despite the lack of Ia, the U937 ceils were an excellent source 
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FIGURE  5.  T4 +  ceils  (106  cdls/ml),  incubated  with  OKT3  and  irradiated  E-  cells,  were 
cultured for 72 h. The antibodies OKT4C (I) or OKT1  (/x) were added after varying periods 
of time, as indicated oll the abscissa. Proliferation  was measured at 72 h. 
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FIGURE  6.  Monocyte-depleted  T4 +  cells  (106  cells/ml)  were  cultured  in  the  presence  of 
OKT3  (500 ng/ml) and irradiated  U937 cells in increasing numbers. Cultures were harvested 
after 72  h, and [~H]thymidine incorporation  measured. OKT4C  (I),  OKTI  (ZX), OKla2  (F'I) 
or medium alone (0) was added. 
to  T4  +  cells  cultured  with  graded  numbers  of irradiated  U937  cells  in  the 
presence  of  OKT3,  and  assessed  proliferation  after  3  d.  The  results  of  a 
representative experiment are shown  in  Fig.  6.  The OKT3-induced activation 
ofT4 + cells in the presence of the Ia- U937 accessory cell was markedly inhibited 
by OKT4C. The control OKT1 antibody was not inhibitory. In addition, OKI2, 
an antibody that binds  to nonpolymorphic regions of class  II  MHC  molecules, 
had no inhibitory effect on activation induced by U937  cells. Taken together, 
these results show that the mechanism of inhibition by OKT4C was independent 
of the interaction of T4 + cells with Ia  + accessory cells. 
To further address  this  point we  found that  T4  + cells could be activated in 
the absence of E- accessory cells if OKT3 was presented on Sepharose beads. In 
a  representative experiment (Fig.  7),  we found that T4  + cells,  depleted of any 
residual  monocytes by OKM2  and  C,  could be activated  by OKT3  covalently 
linked to beads. As expected, in the absence of accessory cells, the T4  + cells did 
not respond to soluble OKT3.  However, these T4  + cells did proliferate in the 
presence of OKT3  bound  to Sepharose beads.  Importantly,  OKT4C,  but  not 
OKT4 or OKT 1, significantly inhibited this activation. These experiments show 
that,  even  in  the  absence  of accessory  cells,  OKT4C  could  inhibit  T4  +  cell 
activation. BANK  AND  CHESS  1299 
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F~GUR~  7,  Monocyte-depleted  T4*  cells  (10  ~ cells/ml) were  cultured  in  the  presence  of 
medium, soluble OKT3, or Sepharose-bound OKT3.  Antibodies OKT4C, OKT4, or OKT1 
were  added  to  cultures  containing  Sepharose-bound  OKT3.  After overnight pulse,  [3H]- 
thymidine incorporation was measured. 
Discussion 
These studies were undertaken  to further explore the functional  role of the 
T4 molecule in T  cell activation. Specifically, we asked whether the T4 molecule 
participates in T  cell activation solely by interacting with class II MHC molecules. 
To address this question, we devised experimental approaches to activating T4 + 
cells by OKT3  in  the absence of Ia-bearing accessory cells, and asked whether 
anti-T4  antibodies  could  still  inhibit  function.  This  experimental  system  was 
chosen because T4 + cell activation by anti-T3 bears analogies to antigen-mediated 
triggering.  For example,  triggering  T4 + cells with either anti-T3  or antigen  in 
the presence of Ia + accessory cells results in comodulation of the T  cell receptor- 
T3  molecular  complex,  with  ensuing  interleukin  2  (IL-2)  production,  IL-2 
receptor expression, and proliferation (29, 30). 
Our experiments  show that  certain  antibodies against  T4  specifically inhibit 
the  proliferative  response  to  anti-T3  (Fig.  1).  Since  our  initial  experiments 
included autologous  Ia + accessory cells, one interpretation  of these results was 
that  OKT4C inhibits  by abrogating putative T4-Ia interactions.  This interpre- 
tation  has  been  offered  as  an  explanation  for  experiments  in  which  anti-T4 
antibodies inhibit T4 + cell-mediated help, cytotoxicity, or proliferation (9-14). 
In  further  experiments,  however,  we ascertained  that  this  could not be the 
only explanation  for anti-T4-induced inhibition.  In these experiments, we took 
advantage of the fact that in some experimental systems, Ia- cells are capable of 
functioning as accessory cells. For example, in the murine system, concanavalin 
A (Con A)-induced T  cell proliferation  can be supported by Ia- fibroblasts. We 
therefore rigorously depleted our T4 + population of Ia-bearing monocytes, and 
replaced them with an  Ia- macrophage-derived  cell line,  U937.  Evidence that 
the depletion of monocytes was in fact complete was demonstrated functionally 
by the lack of response of T4 + cells to soluble OKT3, and also by complete lack 
of OKMl-bearing  cells by cytofluorographic analysis.  The  U937 cell line lacks 
Ia surface molecules, but bears the OKM 1 cell surface marker, and is capable of 
producing IL-1  (31).  Our experiments show that  U937 could substitute for Ia  + 
macrophages  in supporting anti-T3  triggering  of T4 + cells.  More importantly, 1300  PERTURBATION  OF  T4  MOLECULE  TRANSMITS  NEGATIVE  SIGNAL 
anti-T4 potently inhibited this response (Fig. 6). These results are analogous to 
the  findings of Beckoff et  al.  (32),  who  showed  that  anti-L3T4,  the  mouse 
analogue of T4, inhibited Con A-driven T  cell responses in the presence of Ia- 
fibroblasts.  Taken  together,  these  data  show  that  Ia  + accessory cells  are  not 
required for the inhibition of T4 ÷ cell activation by antibodies against T4. 
In our last set of experiments, we asked whether anti-T4 inhibition could be 
observed in the virtual absence of accessory cells.  It has recently been demon- 
strated  that  it  is  possible  to  activate  T  cells  with  anti-T3  in  the  absence  of 
accessory cells. For example, Weiss et al. (33) activated theJurkat T cell leukemia 
by anti-T3 in the presence of phorbol-12-myristate-13-acetate (PMA).  In addi- 
tion, in the apparent absence of accessory cells,  Meuer et al.  (30)  were able to 
activate long term-cultured antigen-specific T  cell clones with Sepharose-bound 
anti-T3.  In  our  experiments,  fresh  peripheral  T4 + cells  were  activated with 
Sepharose-bound  anti-T3.  Under  these  conditions,  we  showed  that  anti-T4 
antibodies markedly inhibit T4  + cell activation (Fig. 7). These results suggested 
that the T4 molecule is capable of regulating T  cell function independently of 
interactions with accessory cells,  and ruled out the formal possibility that anti- 
T4 inhibits by abrogating the putative interaction of T4 with non-MHC mole- 
cules on the surface of accessory cells. We cannot rule out the possibility that the 
T4 molecule may interact with other surface components of the T4  + cell itself. 
Taken together, our data is consistent with the hypothesis that the T4 molecule 
may function as  an  independent transducer of negative signals to  the  T  cell 
surface. This hypothesis is not incompatible with the idea that the T4 molecule 
serves as a receptor for class II MHC antigens. If the T4 molecule were in fact 
the receptor for Ia molecules, then negative signals transmitted by T4-Ia inter- 
actions  could  be  advantageous  in  certain  situations.  Since  T4 +  cells  usually 
interact  with  Ia-bearing accessory  cells  in  lymphoid tissue  in  the  absence  of 
antigen (34, 35),  these cells would usually be receiving negative signals. Only in 
the  presence  of a  strong positive  signal,  delivered  by  the  interaction  of the 
polymorphic T cell antigen receptor with antigen and Ia, could the cell be turned 
on. This view requires the postulate that either the negative signal delivered by 
the T4-Ia interaction is easily overcome by higher-avidity antigen interactions, 
or that the  T4  molecule, in  the  presence of antigen, could deliver a  positive 
signal. Thus, T4 might function as a switch-like molecule on the T  cell surface, 
being turned off when T4 interacts with Ia alone, and turned on when antigen 
is present.  Recently, a cDNA encoding the T4 molecule has been isolated and 
sequenced (36).  The deduced amino acid sequence demonstrates an N-terminal 
domain with amino acid and structural homology to immunoglobulin light chains. 
In addition, the  molecule has  a  cytoplasmic domain of 41  amino acids.  This 
structural data is compatible with the idea that T4 can both function as a receptor 
for Ia and deliver regulatory signals to the T  cell. 
Summary 
We investigated the functional role of the T4 molecule in the activation of T 
cells by OKT3. T4 + cells were induced to proliferate by OKT3 and erythrocyte 
rosette-negative accessory cells in the presence or absence of OKT4C, OKT4, 
and OKT1. OKT4C (IgG1), and not OKT4 (IgG2) or OKT1  (IgG1) inhibited BANK  AND  CHESS  1301 
proliferation when OKT4C  was added during the first 24 h  of cell culture. The 
inhibition  of OKT3  activation  by OKT4C  did  not  require  Ia  + accessory cells, 
since T4 ÷ cells could be activated by OKT3  in the  presence of Ia- U937  cells, 
and this activation was markedly inhibited  by OKT4C.  Furthermore,  T4  + cells 
could be induced  to proliferate by OKT3  covalently linked to Sepharose beads, 
in  the absence of any accessory cells.  Under these conditions,  OKT4C,  but not 
OKT4  or  OKT1  significantly  inhibited  proliferation.  These data  demonstrate 
that at least one mechanism by which anti-T4 antibodies inhibit T  cell activation 
is independent  of any putative role of T4 molecules in the recognition of Ia on 
target cells.  The data are compatible with the  idea that perturbation  of the T4 
molecules can transmit a  negative signal to T4 + cells. 
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